JUPITER, Fla., Aug. 1, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on stem cell-based therapeutics, today announced the issuance of a shareholder letter by Chief Executive Officer,Mark Weinreb, providing an update to shareholders on the Company's progress.
The shareholders were advised as follows:
Over the past 12 months, BRT's substantial investment in research and development has allowed the Company to continue executing on its growth strategy. There have been many developments, both operationally and scientifically, that have positioned the Company well as a growing stem cell biotechnology company with a specific focus on cellular treatments and therapies for certain medical applications.
Below are some of the Company's accomplishments and activities over the past 12 months:
"Based on these accomplishments, we are excited for what lies ahead in the near and long term," states CEO Mark Weinreb. "We continue to make speedy and efficient progress with our programs and look forward to further advancements regarding each of our exciting initiatives. I would like to thank all of our shareholders for their continued support. We will continue to work diligently to further execute our growth plan so that BioRestorative Therapies will be able to mature into a prominent life sciences company."
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. ("BRT"),www.biorestorative.com, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, designed for patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives:
The Company also offers plant stem cell-based facial creams and beauty products under theStem Pearlsbrand atwww.stempearls.com.
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
Investor Contact:Adam Holdsworth ProActive Capital 646.862.4607 adamh@proactivecapital.com
View original post here:
BioRestorative Therapies Provides Company Updates with Shareholder Letter